{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-082637","form_type":"8-K","ticker":"ARMP","cik":"0000921114","company_name":"Armata Pharmaceuticals, Inc.","filed_at":"2024-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.363867+00:00","generated_at":"2026-05-31T16:34:52.884502+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Armata formalizes CMO Pastagia's salary at $456,800; improves severance to 12 months","bullets":["Dr. Pastagia's base salary confirmed at $456,800 (effective Jan 1, 2023).","Target bonus increased to 50% of salary for FY2024; no 2023 bonus awarded.","Eligible for annual equity grants starting 2025; current intent ~$300,000 fair value.","Severance extended from 6 to 12 months base salary for involuntary termination without cause.","Amendment also updates title to Chief Medical Officer (serving since Jan 1, 2023)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-082637","json":"https://secwatch.observer/filing/0001104659-24-082637.json","markdown":"https://secwatch.observer/filing/0001104659-24-082637.md","text":"https://secwatch.observer/filing/0001104659-24-082637.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921114/000110465924082637/0001104659-24-082637-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921114/000110465924082637/tm2420145d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T16:34:52.884502+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}